(Q40733816)
Statements
1 reference
Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor (English)
1 reference
LeMaistre CF
1 reference
Meneghetti C
1 reference
Rosenblum M
1 reference
Reuben J
1 reference
Parker K
1 reference
Shaw J
1 reference
Deisseroth A
1 reference
Woodworth T
1 reference
Parkinson DR
1 reference
1 May 1992
1 reference
1 reference
79
1 reference
10
1 reference
2547-2554
1 reference
Identifiers
1 reference